JPET xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Maher, J. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Maher, J. F.
Journal of Pharmacology And Experimental Therapeutics, Vol. 174, Issue 3, 450-455, 1970
Copyright © 1970 by American Society for Pharmacology and Experimental Therapeutics


DETERMINANTS OF SERUM HALF-LIFE OF GLUTETHIMIDE IN INTOXICATED PATIENTS

John F. Maher 1

1 Department of Medicine, Georgetown University School of Medicine, Washington, D.C.

To determine factors that influence the disappearance of glutethimide from serum of intoxicated patients an evaluation was made by determination of the levels in serum sampled before and after various types of therapy. The calculated duration of time for a serum level to be reduced to half its initial value, the serum half-life in intoxicated patients, averaged 40.1 hours. The half-life in patients treated with hemodialysis was 14.6 hours. Renal failure did not prolong the serum half-life nor did diuresis shorten it. There was a positive correlation between the serum level and the serum half-life, r = 0.56. This is interpreted as consistent with rate-limited enzymatic degradation of glutethimide. The serum half-life did not correlate with the time interval after ingestion in this group of patients. In some patients with hypotension the serum half-life was prolonged, suggesting impaired perfusion of tissue responsible for elimination of glutethimide, presumably the liver.

Submitted on August 18, 1969
Accepted on May 10, 1970







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1970 by the American Society for Pharmacology and Experimental Therapeutics.